{"cdcTestId":"2013-0578","testcaseName":"Dose # 1 of PCV 13 at age 24 months.  Series complete.","vaccineGroup":"PCV","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Not recommended: series complete","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2020-10-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"-","earliestDate":"0001-01-01T00:00:00","recommendedDate":"0001-01-01T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"PREVNAR 13","cvx":"133","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-29T07:23:50.84","generalDescription":"This test case describes when dose #1 of the Pneumococcal 13 vaccine is administered at age 24 months that the dose is considered to be valid.  No additional dose should be forecasted.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}